Exploiting Dendrimer Multivalency To Combat Emerging and Re-Emerging Infectious Diseases

被引:133
作者
Mintzer, Meredith A. [2 ]
Dane, Eric L. [2 ]
O'Toole, George A. [3 ]
Grinstaff, Mark W. [1 ,2 ]
机构
[1] Boston Univ, Dept Biomed Engn, Metcalf Ctr Sci & Engn, Boston, MA 02215 USA
[2] Boston Univ, Dept Chem, Boston, MA 02215 USA
[3] Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03755 USA
基金
美国国家卫生研究院;
关键词
dendrimer; dendritic polymers; bacteria; antimicrobial; infection; antibacterial agents; coatings; carriers; drug delivery; HEAT-LABILE ENTEROTOXIN; OLIGOSACCHARIDE-DERIVATIZED DENDRIMERS; LIPOSOME-ENCAPSULATED GENTAMICIN; POLY(PROPYLENE IMINE) DENDRIMERS; GUINEA-PIG MODEL; TOXIN-B-SUBUNIT; ESCHERICHIA-COLI; CHOLERA-TOXIN; ANTIMICROBIAL POLYMERS; POLY(AMIDOAMINE) DENDRIMERS;
D O I
10.1021/mp2005033
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The emergence and re-emergence of bacterial strains that are resistant to current antibiotics reveal the clinical need for new agents that possess broad-spectrum antibacterial activity. Furthermore, bacteriophobic coatings that repel bacteria are important for medical devices, as the lifetime, reliability, and performance of implant devices are hindered by bacterial adhesion and infection. Dendrimers, a specific class of monodisperse macromolecules, have recently shown potential to function as both antibacterial agents and antimicrobial surface coatings. This review discusses the limitations with currently used antibacterial agents and describes how various classes of dendrimers, including glycodendrimers, cationic dendrimers, anionic dendrimers, and peptide dendrimers, have the potential to improve upon or replace certain antibiotics. Furthermore, the unexplored areas in this field of research will be mentioned to present opportunities for additional studies regarding the use of dendrimers as antimicrobial agents.
引用
收藏
页码:342 / 354
页数:13
相关论文
共 124 条
[1]   Investigating the Effect of Increasing Charge Density on the Hemolytic Activity of Synthetic Antimicrobial Polymers [J].
Al-Badri, Zoha M. ;
Som, Abhigyan ;
Lyon, Sarah ;
Nelson, Christopher F. ;
Nusslein, Klaus ;
Tew, Gregory N. .
BIOMACROMOLECULES, 2008, 9 (10) :2805-2810
[2]   Novel multivalent mannose compounds and their inhibition of the adhesion of type 1 fimbriated uropathogenic E. coli [J].
Appeldoorn, CCM ;
Joosten, JAF ;
el Maate, FA ;
Dobrindt, U ;
Hacker, J ;
Liskamp, RMJ ;
Khan, AS ;
Pieters, RJ .
TETRAHEDRON-ASYMMETRY, 2005, 16 (02) :361-372
[3]  
Arciola Carla Renata, 2002, Expert Rev Mol Diagn, V2, P478, DOI 10.1586/14737159.2.5.478
[4]   Trends in infectious disease mortality in the United States during the 20th century [J].
Armstrong, GL ;
Conn, LA ;
Pinner, RW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (01) :61-66
[5]   Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine [J].
Astruc, Didier ;
Boisselier, Elodie ;
Ornelas, Catia .
CHEMICAL REVIEWS, 2010, 110 (04) :1857-1959
[6]   Long-circulating sterically stabilized liposomes in the treatment of infections [J].
Bakker-Woudenberg, IAJM ;
Schiffelers, RM ;
Storm, G ;
Becker, MJ ;
Guo, L .
LIPOSOMES, PT E, 2005, 391 :228-260
[7]   Dendrimer-silver complexes and nanocomposites as antimicrobial agents [J].
Balogh, L ;
Swanson, DR ;
Tomalia, DA ;
Hagnauer, GL ;
McManus, AT .
NANO LETTERS, 2001, 1 (01) :18-21
[8]   Emerging and re-emerging infectious diseases: The third epidemiologic transition [J].
Barrett, R ;
Kuzawa, CW ;
McDade, T ;
Armelagos, GJ .
ANNUAL REVIEW OF ANTHROPOLOGY, 1998, 27 :247-271
[9]  
Block S.S., 1983, DISINFECTION STERILI, V3rd
[10]   Strong inhibition of cholera toxin binding by galactose dendrimers [J].
Branderhorst, Hilbert M. ;
Liskamp, Rob M. J. ;
Visser, Gerben M. ;
Pieters, Roland J. .
CHEMICAL COMMUNICATIONS, 2007, (47) :5043-5045